Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/23827
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2022-01-03T13:17:31Z-
dc.date.available2022-01-03T13:17:31Z-
dc.date.issued2011-07-20-
dc.identifier.citationAytaç, B. ve Vuruşkan, H. (2011). "Clinicopathologic features of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens". World Journal of Surgical Oncology, 9(81).en_US
dc.identifier.issn1477-7819-
dc.identifier.urihttps://doi.org/10.1186/1477-7819-9-81-
dc.identifier.urihttps://wjso.biomedcentral.com/articles/10.1186/1477-7819-9-81-
dc.identifier.urihttp://hdl.handle.net/11452/23827-
dc.description.abstractBackground: The aim of this study is to review all features of incidentally discovered prostate adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer. Methods: The medical charts of 300 male patients who underwent radical cystoprostatectomy for bladder cancer between 1997 and 2005 were retrospectively reviewed. The mean age of the patients was 62 (range 51-75) years. Results: Prostate adenocarcinoma was present in 60 (20%) of 300 specimens. All were acinar adenocarcinoma. Of these, 40 (66.7%) were located in peripheral zone, 20 (33.3%) had pT2a tumor, 12 (20%) had pT2b tumor, 22(36.7%) had pT2c and, 6 (10%) had pT3a tumor. Gleason score was 6 or less in 48 (80%) patients. Surgical margins were negative in 54 (90%) patients, and tumor volume was less than 0.5 cc in 23 (38.3%) patients. Of the 60 incidentally detected cases of prostate adenocarcinoma 40 (66.7%) were considered clinically significant. Conclusion: Incidentally detected prostate adenocarcinoma is frequently observed in radical cystoprostatectomy specimens. The majority are clinically significant.en_US
dc.language.isoenen_US
dc.publisherBmcen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectOncologyen_US
dc.subjectSurgeryen_US
dc.subjectBladder canceren_US
dc.subjectCystoprostatectomyen_US
dc.subjectIncidentalen_US
dc.subjectProstate canceren_US
dc.subjectTransitional cell carcinomaen_US
dc.subjectBladder canceren_US
dc.subjectUrothelial carcinomaen_US
dc.subjectCystectomyen_US
dc.subjectPrevalenceen_US
dc.subjectPathologyen_US
dc.subjectVolumeen_US
dc.subject.meshAdenocarcinomaen_US
dc.subject.meshAgeden_US
dc.subject.meshAged, 80 and overen_US
dc.subject.meshDiagnosis, differentialen_US
dc.subject.meshFollow-up studiesen_US
dc.subject.meshHumansen_US
dc.subject.meshIncidental findingsen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshPrognosisen_US
dc.subject.meshProstate-specific antigenen_US
dc.subject.meshProstatectomyen_US
dc.subject.meshProstatic neoplasmsen_US
dc.subject.meshRetrospective studiesen_US
dc.titleClinicopathologic features of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimensen_US
dc.typeArticleen_US
dc.identifier.wos000293967400001tr_TR
dc.identifier.scopus2-s2.0-79960554118tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Cerrahi Patoloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Üroloji Anabilim Dalı.tr_TR
dc.identifier.volume9tr_TR
dc.identifier.issue81tr_TR
dc.relation.journalWorld Journal of Surgical Oncologyen_US
dc.contributor.buuauthorAytaç, Berna-
dc.contributor.buuauthorVuruşkan, Hakan-
dc.contributor.researcheridAAH-9746-2021tr_TR
dc.identifier.pubmed21774802tr_TR
dc.subject.wosOncologyen_US
dc.subject.wosSurgeryen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.wos.quartileQ4 (Oncology)en_US
dc.wos.quartileQ3 (Surgery)en_US
dc.contributor.scopusid56527372000tr_TR
dc.contributor.scopusid6507328150tr_TR
dc.subject.scopusCystectomy; Prostate-Specific Antigen; Urinary Bladder Neoplasmsen_US
dc.subject.emtreeProstate specific antigenen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAgeden_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBladder canceren_US
dc.subject.emtreeCancer diagnosisen_US
dc.subject.emtreeCancer patienten_US
dc.subject.emtreeCystectomyen_US
dc.subject.emtreeGleason scoreen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMedical record reviewen_US
dc.subject.emtreeProstate adenocarcinomaen_US
dc.subject.emtreeTissue sectionen_US
dc.subject.emtreeTumor volumeen_US
dc.subject.emtreeAdenocarcinomaen_US
dc.subject.emtreeComparative studyen_US
dc.subject.emtreeDifferential diagnosisen_US
dc.subject.emtreeFollow upen_US
dc.subject.emtreeIncidental findingen_US
dc.subject.emtreeMetabolismen_US
dc.subject.emtreeMethodologyen_US
dc.subject.emtreeMiddle ageden_US
dc.subject.emtreePathologyen_US
dc.subject.emtreePrognosisen_US
dc.subject.emtreeProstate tumoren_US
dc.subject.emtreeProstatectomyen_US
dc.subject.emtreeRetrospective studyen_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
File Description SizeFormat 
Aytaç_Vuruşkan_2011.pdf356.23 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons